---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-204310"
form_type: "8-K"
ticker: "JAGX"
cik: "0001585608"
company_name: "Jaguar Health, Inc."
filed_at: "2026-05-04T23:59:59+00:00"
generated_at: "2026-05-14T23:54:40.422401+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Jaguar Health cures Nasdaq publicly held shares deficiency via warrant exercises after reverse split

## Summary
- Received Nasdaq notice on May 1, 2026 for non-compliance with minimum 500,000 publicly held shares after 1-for-35 reverse split on April 30.
- Post-split publicly held shares were ~401,226, below the 500,000 requirement.
- On May 4, 2026, warrant exercises increased publicly held shares to 513,939.
- Company now has 513,974 total shares outstanding; awaiting Nasdaq formal confirmation of compliance.
- Reverse split had also triggered continued non-compliance with bid price rule until cure.

## SEC filing metadata
- accession: 0001193125-26-204310
- form_type: 8-K
- ticker: JAGX
- cik: 0001585608
- company_name: Jaguar Health, Inc.
- filed_at: 2026-05-04T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1585608/000119312526204310/0001193125-26-204310-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1585608/000119312526204310/d941132d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-204310
- JSON: https://secwatch.observer/filing/0001193125-26-204310.json
- Plain text: https://secwatch.observer/filing/0001193125-26-204310.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.